Last update 11 May 2025

EG COVID vaccine (EyeGene)

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms
COVID-19 vaccine- Eyegene, EG-COVID-001, EG-COVID-003
Target
SARS-CoV-2 antigen
Action
inhibitors
Mechanism
SARS-CoV-2 antigen inhibitors
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
EyeGene, Inc.EyeGene, Inc.
Active Organization
EyeGene, Inc.EyeGene, Inc.Novotech (Australia) Pty Ltd.Novotech (Australia) Pty Ltd.
Inactive Organization-
License Organization
REYON PHARMACEUTICAL Co., Ltd.REYON PHARMACEUTICAL Co., Ltd.EyeGene, Inc.EyeGene, Inc.TriLink BioTechnologies LLCTriLink BioTechnologies LLC
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with EG COVID vaccine (EyeGene)
NCT05188469
/ CompletedPhase 1/2
A Phase I/IIa (Multi-center, Open-label, Phase I and Multi-center, Open-label, Phase IIa ) Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers
KCT0006670
/ RecruitingPhase 1/2
A Phase I/IIa (dose-escalation, single-center, open-label, Phase I and randomized, observer-blind, multi-center, placebo-controlled, Phase IIa) study to determine safety, tolerance and immunogenicity of a preventive COVID-19 vaccine ‘mRNA SARS-CoV-2 Vaccine (EG-COVID)’ in healthy adult
100 Clinical Results associated with EG COVID vaccine (EyeGene)
Login to view more data
100 Translational Medicine associated with EG COVID vaccine (EyeGene)
Login to view more data
100 Patents (Medical) associated with EG COVID vaccine (EyeGene)
Login to view more data
100 Deals associated with EG COVID vaccine (EyeGene)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
Australia
Novotech (Australia) Pty Ltd.Novotech (Australia) Pty Ltd.
22 Mar 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free